KURA ONCOLOGY INC. - COMMON STOCK

Kura Oncology Reports Third Quarter 2024 Financial Results

07 ноя 2024 16:05:01 Источник Nasdaq GlobeNewswire

Kura Oncology to Present Updated Data from KOMET-007 Combination Trial of Ziftomenib at ASH Annual Meeting

05 ноя 2024 09:09:54 Источник Nasdaq GlobeNewswire

Kura Oncology to Report Third Quarter 2024 Financial Results

31 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Reports Preclinical Data Supporting Opportunity for Ziftomenib in Treatment of Gastrointestinal Stromal Tumors (GIST)

24 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology to Present New Data Supporting Combination of KO-2806 with KRAS G12C and Pan-RAS Inhibitors

23 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology

30 сен 2024 18:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Appoints Michael Vasconcelles, M.D., to Board of Directors

17 сен 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology to Participate in Cantor Global Healthcare Conference

10 сен 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Reports Second Quarter 2024 Financial Results

08 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire

Kura Oncology Announces FDA Clearance of IND Application for Menin Inhibitor Ziftomenib in Advanced Gastrointestinal Stromal Tumors (GIST)

08 авг 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology to Report Second Quarter 2024 Financial Results

01 авг 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 июл 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes

24 июн 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

07 июн 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology to Participate in Jefferies Global Healthcare Conference

29 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML

14 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology to Participate in Bank of America Securities Healthcare Conference

08 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 май 2024 07:30:00 Источник Nasdaq GlobeNewswire

Kura Oncology Reports First Quarter 2024 Financial Results

02 май 2024 16:05:00 Источник Nasdaq GlobeNewswire

Kura Oncology to Report First Quarter 2024 Financial Results

25 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire